TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT

Translocator protein (TSPO) 18 kDa overexpression has been observed in a large variety of human cancers, especially breast cancers. PK 11195 an isoquinoline analogue, is one of the ligands of highers TSPO binding affinity. Due to the long biological half life of our photosensitizers there is a need to label them with a long lived radiosotopye, for example I-124. Our objectives are to find translocator, protein targeted photosensitizers for both tumor imaging (PET) and photodynamic therapy (PDT)-I-PK 11195 is conjugated with the tumor avid photosensitizer HPPH. We find that those two tumor avid components complement each other and make the conjugate molecule even more tumor avid, compared to the photosensitizer itself, the conjugate is found to show improved PDT efficacy. It is concluded that I-PK 11195 can be a good vehicle to deliver radionuclide and photosensitizer to TSPO overexpressed tumor regions. Such conjugates could be useful for both tumor imaging (PET) and PDT.